Australia, Jan. 8 -- DEKA Research & Development Corp., owns the trademark (2407822) for 'TWIIST' till Aug. 18, 2033.

Status: protected: Registered/protected

Classes: 5 [Infusion cartridges filled with medication; adhesive overlays in the nature of adhesive medical tape, bandages.], 9 [Software as a medical device (SaMD), downloadable, for predicting analyte levels and adjusting infusion pump settings based on personalized data.], 10 [Medical devices, namely, infusion and injection devices for administering drugs and measured amounts of solutions into the bloodstream over time; apparatus for monitoring blood analyte levels; wearable subcutaneous drug delivery devices, sold empty in the nature of injectors; on-body injectors; chronic disease management devices, in the nature of medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of analytes in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor; pouches and mounts for use with infusion pumps.], 35 [Administration of a trade-in and upgrade program for drug delivery and chronic disease management devices.], 42 [Software-as-a-service (SaaS) featuring software for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data obtained from medical sensors that are implanted or inserted into the human body; hosting an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to managing chronic disease, medication and analyte levels.] and 44 [Interactive medical monitoring, reporting and alert services for infusion pump users for monitoring and managing chronic disease; providing medical information related to chronic diseases, including advice on treatment options and chronic disease management from a web site; providing medical information for consumers and healthcare practitioners via online databases; medical consultation services, namely, patient ambassador program to communicate medical information to people with chronic disease.]

Type of Mark: Word

Date of Acceptance: Oct. 23, 2024

Registration Advertised: Jan. 7

For further details contact Henry Hughes IP Ltd. and Mark E. Tetreault.

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2407822.

Disclaimer: Curated by HT Syndication.